Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Lagunin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Biomeditsinskaia Khimiia|December 24, 2024
Repositioning of drugs for the treatment of major depressive disorder based on prediction of drug-induced gene expression changesS M Ivanov, A A Lagunin, V V Poroikov
Biochemistry. Biokhimiia|March 11, 2015
Quantitative analysis of structure-activity relationships of tetrahydro-2H-isoindole cyclooxygenase-2 inhibitorsV R Khayrullina, A Ya Gerchikov, A A Lagunin, et al.
SAR and QSAR in Environmental Research|May 22, 2007
A new approach to QSAR modelling of acute toxicityA A Lagunin, A V Zakharov, D A Filimonov, et al.
Molekuliarnaia Biologiia|December 14, 2025
[Prediction of New Nε-Acetylation Sites in the Human Proteome Based on Molecular Multilevel Neighborhoods of Atom Descriptors]N V Lebedev, D A Filimonov, V V Poroikov, et al.
SAR and QSAR in Environmental Research|December 22, 2009
QNA-based 'Star Track' QSAR approachD A Filimonov, A V Zakharov, A A Lagunin, et al.
SAR and QSAR in Environmental Research|August 26, 2015
PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approachP V Pogodin, A A Lagunin, D A Filimonov, et al.
Biomeditsinskaia Khimiia|May 20, 2014
[Computer modeling of blood brain barrier permeability of physiologically active compounds]O A Raevskiĭ, S L Solodova, A A Lagunin, et al.
SAR and QSAR in Environmental Research|March 1, 2012
In silico fragment-based drug design using a PASS approachO A Filz, A A Lagunin, D A Filimonov, et al.
Current Medicinal Chemistry|February 7, 2003
Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structuresA V Stepanchikova, A A Lagunin, D A Filimonov, et al.
Biomeditsinskaia Khimiia|June 3, 2006
[Quantitative structure-activity relationships of cyclin-dependent kinase 1 inhibitors]A V Zakharov, A A Lagunin, D A Filimonov, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Biomeditsinskaia Khimiia|December 24, 2024
Repositioning of drugs for the treatment of major depressive disorder based on prediction of drug-induced gene expression changesS M Ivanov, A A Lagunin, V V Poroikov
Biochemistry. Biokhimiia|March 11, 2015
Quantitative analysis of structure-activity relationships of tetrahydro-2H-isoindole cyclooxygenase-2 inhibitorsV R Khayrullina, A Ya Gerchikov, A A Lagunin, et al.
SAR and QSAR in Environmental Research|May 22, 2007
A new approach to QSAR modelling of acute toxicityA A Lagunin, A V Zakharov, D A Filimonov, et al.
Molekuliarnaia Biologiia|December 14, 2025
[Prediction of New Nε-Acetylation Sites in the Human Proteome Based on Molecular Multilevel Neighborhoods of Atom Descriptors]N V Lebedev, D A Filimonov, V V Poroikov, et al.
SAR and QSAR in Environmental Research|December 22, 2009
QNA-based 'Star Track' QSAR approachD A Filimonov, A V Zakharov, A A Lagunin, et al.
SAR and QSAR in Environmental Research|August 26, 2015
PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approachP V Pogodin, A A Lagunin, D A Filimonov, et al.
Biomeditsinskaia Khimiia|May 20, 2014
[Computer modeling of blood brain barrier permeability of physiologically active compounds]O A Raevskiĭ, S L Solodova, A A Lagunin, et al.
SAR and QSAR in Environmental Research|March 1, 2012
In silico fragment-based drug design using a PASS approachO A Filz, A A Lagunin, D A Filimonov, et al.
Current Medicinal Chemistry|February 7, 2003
Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structuresA V Stepanchikova, A A Lagunin, D A Filimonov, et al.
Biomeditsinskaia Khimiia|June 3, 2006
[Quantitative structure-activity relationships of cyclin-dependent kinase 1 inhibitors]A V Zakharov, A A Lagunin, D A Filimonov, et al.
Pageof 4